Marciela M. DeGrace,Elodie Ghedin,Matthew B. Frieman,Florian Krammer,Alba Grifoni,Arghavan Alisoltani,Galit Alter,Rama R. Amara,Ralph S. Baric,Dan H. Barouch,Jesse D. Bloom,Louis-Marie Bloyet,Gaston Bonenfant,Adrianus C. M. Boon,Eli A. Boritz,Debbie L. Bratt,Traci L. Bricker,Liliana Brown,William J. Buchser,Juan Manuel Carreño,Liel Cohen-Lavi,Tamarand L. Darling,Meredith E. Davis-Gardner,Bethany L. Dearlove,Han Di,Meike Dittmann,Nicole A. Doria-Rose,Daniel C. Douek,Christian Drosten,Venkata-Viswanadh Edara,Ali Ellebedy,Thomas P. Fabrizio,Guido Ferrari,Will M. Fischer,William C. Florence,Ron A. M. Fouchier,John Franks,Adolfo García-Sastre,Adam Godzik,Ana Silvia Gonzalez-Reiche,Aubree Gordon,Bart L. Haagmans,Peter J. Halfmann,David D. Ho,Michael R. Holbrook,Yaoxing Huang,Sarah L. James,Lukasz Jaroszewski,Trushar Jeevan,Robert M. Johnson,Terry C. Jones,Astha Joshi,Yoshihiro Kawaoka,Lisa Kercher,Marion P. G. Koopmans,Bette Korber,Eilay Koren,Richard A. Koup,Eric B. LeGresley,Jacob E. Lemieux,Mariel J. Liebeskind,Zhuoming Liu,Brandi Livingston,James P. Logue,Yang Luo,Adrian B. McDermott,Margaret J. McElrath,Victoria A. Meliopoulos,Vineet D. Menachery,David C. Montefiori,Barbara Mühlemann,Vincent J. Munster,Jenny E. Munt,Manoj S. Nair,Antonia Netzl,Anna M. Niewiadomska,Sijy O’Dell,Andrew Pekosz,Stanley Perlman,Marjorie C. Pontelli,Barry Rockx,Morgane Rolland,Paul W. Rothlauf,Sinai Sacharen,Richard H. Scheuermann,Stephen D. Schmidt,Michael Schotsaert,Stacey Schultz-Cherry,Robert A. Seder,Mayya Sedova,Alessandro Sette,Reed S. Shabman,Xiaoying Shen,Pei-Yong Shi,Maulik Shukla,Viviana Simon,Spencer Stumpf,Nancy J. Sullivan,Larissa B. Thackray,James Theiler,Paul G. Thomas,Sanja Trifkovic,Sina Türeli,Samuel A. Turner,Maria A. Vakaki,Harm van Bakel,Laura A. VanBlargan,Leah R. Vincent,Zachary S. Wallace,Li Wang,Maple Wang,Pengfei Wang,Wei Wang,Scott C. Weaver,Richard J. Webby,Carol D. Weiss,David E. Wentworth,Stuart M. Weston,Sean P. J. Whelan,Bradley M. Whitener,Samuel H. Wilks,Xuping Xie,Baoling Ying,Hyejin Yoon,Bin Zhou,Tomer Hertz,Derek J. Smith,Michael S. Diamond,Diane J. Post,Mehul S. Suthar

Abstract:The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced following infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) established the SARS-CoV-2 Assessment of Viral Evolution (SAVE) program. This effort was designed to provide a real-time risk assessment of SARS-CoV-2 variants potentially impacting transmission, virulence, and resistance to convalescent and vaccine-induced immunity. The SAVE program serves as a critical data-generating component of the United States Government SARS-CoV-2 Interagency Group to assess implications of SARS-CoV-2 variants on diagnostics, vaccines, and therapeutics and for communicating public health risk. Here we describe the coordinated approach used to identify and curate data about emerging variants, their impact on immunity, and effects on vaccine protection using animal models. We report the development of reagents, methodologies, models, and pivotal findings facilitated by this collaborative approach and identify future challenges. This program serves as a template for the response against rapidly evolving pandemic pathogens by monitoring viral evolution in the human population to identify variants that could erode the effectiveness of countermeasures.

Early Detection and Surveillance of the SARS-CoV-2 Variant BA.2.86 — Worldwide, July–October 2023

Global surveillance of emerging SARS-CoV-2 variants

Genomic Surveillance of SARS-CoV-2 Variants That Emerged in South and Southeast Asia During Early 2022.

Genomic Surveillance for SARS-CoV-2 — China, September 26, 2022 to January 29, 2023

First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023

Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves

Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program

The emergence and implications of SARS-CoV-2 omicron subvariant BA.2.86 on global health

Early computational detection of potential high-risk SARS-CoV-2 variants

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024

Wastewater-based epidemiological surveillance of SARS-CoV-2 new variants BA.2.86 and offspring JN.1 in south and Southeast Asia

A response playbook for early detection and population surveillance of new SARS-CoV-2 variants in a regional public health laboratory

BA.2.86 variant emergence and spread dynamics through wastewater monitoring in Paris, France

COVID-19: Understanding the New Variants of Concern

Defining the risk of SARS-CoV-2 variants on immune protection

Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus

Global landscape of SARS-CoV-2 genomic surveillance and data sharing

Surveillance strategies for the detection of new pathogen variants across epidemiological contexts

In silico genomic surveillance by CoVerage predicts and characterizes SARS-CoV-2 Variants of Interest

Detecting SARS-CoV-2 BA.2, BA.4, and BA.5 Variants Utilizing a Robust RT-RPA-CRISPR/Cas12a-Based Method — China, 2023

Detection of SARS-CoV-2 B.1.351 (Beta) Variant through Wastewater Surveillance before Case Detection in a Community, Oregon, USA